Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

silica/saratani

Kiungo kimehifadhiwa kwenye clipboard
Ukurasa 1 kutoka 38 matokeo

Fluorescent silica-based nanoparticles

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer. BACKGROUND OF THE INVENTION Early tumor detection and treatment selection is paramount to achieving

Toroidal mesoporous silica nanoparticles (TMSNPs) and related protocells

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION In one aspect, the invention provides novel monodisperse, colloidally-stable, torroidal mesoporous silica nanoparticles (TMSNPs) which are synthesized from ellipsoid-shaped mesoporous silica nanoparticles (MSNPs) which are prepared using an ammonia base-catalyzed method under

Fluorescent silica-based nanoparticles

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer. BACKGROUND OF THE INVENTION Early tumor detection and treatment selection is paramount to achieving

Multimodal silica-based nanoparticles

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer. BACKGROUND OF THE INVENTION Early tumor detection and treatment selection is paramount to achieving

Multimodal silica-based nanoparticles

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer. BACKGROUND OF THE INVENTION Early tumor detection and treatment selection is paramount to achieving

Multimodal silica-based nanoparticles

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Nov. 7, 2017, is named 2003080-1330_SL.txt and is 2,007 bytes in size. FIELD OF THE
FIELD OF THE INVENTION The present invention discloses a novel method to isolate a natural flavonoid; inoscavin A indicated in formula 1, from mushroom F. fastuosus, having promising antiprolifertive activity on rhabdomyosarcoma and thereby communicates its application to use it as a medicinal

Silica-matrix forming compositions, materials formed therefrom, and methods of using the same

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION In tumors, not only there are cancer cells of different phenotypes, but there are also normal cells (e.g., fibroblasts, myoblasts, endothelial cells, epithelial cells, and stromal cells). This makes detecting or isolating cancer cells from tumor specimens and biopsies an

Mesoporous silica compositions for modulating immune responses

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION This invention relates to biocompatible injectable compositions. BACKGROUND OF THE INVENTION Vaccines that require ex vivo manipulation of cells, such as most cell based therapy, lead to poor lymph node homing and limited efficiency. SUMMARY OF THE INVENTION The invention

Anti-cancer active substance from Antrodia camphorata, method for preparing the same and use thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel anti-cancer compound identified in mycelium of Antrodia camphorata, the methods of cultivation, and applications of the said compound. To be more specific, the extracted compound is a bioactive anti-cancer

Immunopotentiating agent having anti-tumor activity

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to an immunopotentiator having an anti-tumor activity, which agent is obtaind from marine chlorellas and useful as foods, drugs, pesticides, reagents, etc. 2. Related Art Statement A large number of anti-tumor active

Testing procedure to aid diagnosis of cancer and evaluate the progress of cancer therapy

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION The present invention relates generally to bioanalytical testing procedures to aid in the diagnosis of cancer and to evaluate therapeutic treatment by antineoplastons. More particularly, the invention relates to a quantitative determination of antineoplaston levels in
CROSS-REFERENCE TO RELATED APPLICATIONS None. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT None. REFERENCE TO SEQUENCE LISTING None. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component is identified as quinic acid lactone. The present
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component previously was identified in vitro as quinic acid
Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge